Open AccessEffects of Tiotropium and Salmeterol/Fluticasone Propionate on Airway Wall Thickness in Chronic Obstructive Pulmonary Disease
Author(s) -
Makoto Hoshino,
Junichi Ohtawa
Publication year - 2013
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000351116
Subject(s) - salmeterol , fluticasone propionate , medicine , copd , fluticasone , airway , tiotropium bromide , gastroenterology , pulmonary function testing , bronchus , inhalation , asthma , respiratory disease , anesthesia , urology , lung , lung function
Triple inhalation therapy with tiotropium (Tio) and salmeterol/fluticasone propionate combination (SFC) is widely used in the treatment of chronic obstructive pulmonary disease (COPD). However, the effects of triple therapy on airway structural changes remain unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom